Onselex

본문 바로가기 주메뉴 바로가기

R&D

Through innovative R&D in nanomedicine, we seek to restore freedom, happiness, and the ability to live fully to those affected by cancer.

Oncology Nanomedicine
The formulation is engineered for biocompatibility and biodegradability through a proprietary 16-step nanoprocessing method.
Patents
Onselex has built a broad intellectual property portfolio covering its nanoparticle platform and potential applications.

PIPELINE

Onselex is expanding its pipeline by developing innovative and effective new drugs.

Press Releases
Notices

2026.07.30 ONX presentation
2026.07.30 Onselex Executive Summary
2024.04.14 An article from the Let’s Win Pancreatic Cancer Foundation about Onselex.
2022.11.02 Onselex Welcomes Two Distinguished Medical Innovators to its Clinical Advisory Board
2021.06.15 This is a Promotional video for Onselex (please watch)